Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Income towards Parent Company: 2012-2025

Historic Income towards Parent Company for Phibro Animal Health (PAHC) over the last 13 years, with Sep 2025 value amounting to $26.5 million.

  • Phibro Animal Health's Income towards Parent Company rose 280.32% to $26.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $63.1 million, marking a year-over-year increase of 123.38%. This contributed to the annual value of $43.5 million for FY2025, which is 228.61% up from last year.
  • As of Q3 2025, Phibro Animal Health's Income towards Parent Company stood at $26.5 million, which was up 112.71% from $12.5 million recorded in Q2 2025.
  • In the past 5 years, Phibro Animal Health's Income towards Parent Company ranged from a high of $26.5 million in Q3 2025 and a low of -$8.0 million during Q3 2023.
  • Moreover, its 3-year median value for Income towards Parent Company was $8.6 million (2023), whereas its average is $9.3 million.
  • As far as peak fluctuations go, Phibro Animal Health's Income towards Parent Company plummeted by 307.86% in 2023, and later surged by 280.32% in 2025.
  • Over the past 5 years, Phibro Animal Health's Income towards Parent Company (Quarterly) stood at $17.5 million in 2021, then slumped by 58.72% to $7.2 million in 2022, then crashed by 82.33% to $1.3 million in 2023, then soared by 150.00% to $3.2 million in 2024, then soared by 280.32% to $26.5 million in 2025.
  • Its Income towards Parent Company stands at $26.5 million for Q3 2025, versus $12.5 million for Q2 2025 and $20.9 million for Q1 2025.